MEDICINOVA, INC. Operating Lease, Liability, Noncurrent
MEDICINOVA, INC. (MNOV) had Operating Lease, Liability, Noncurrent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Noncurrent $0.00.
- 2026-03-31: Operating Lease, Liability, Noncurrent $0.00.
- 2025-12-31: Operating Lease, Liability, Noncurrent $17.13K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $74.40K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 |
| 2025-12-31 | $17.13K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $74.40K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $117.04K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $165.20K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $211.46K 10-K · filed 2026-03-10 |
| 2024-09-30 | $255.15K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $302.48K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $351.19K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $410.66K 10-K · filed 2025-02-19 |
| 2023-09-30 | $463.84K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $519.68K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $489.38K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $523.62K 10-K · filed 2024-02-15 |
| 2022-09-30 | $555.84K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $587.40K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $632.87K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $694.67K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $737.72K 10-Q · filed 2021-11-12 |
| 2021-03-31 | $2.21K 10-Q · filed 2022-05-12 |
| 2020-12-31 | $2.71K 10-K · filed 2022-02-16 |
| 2019-12-31 | $182.58K 10-K · filed 2021-02-19 |
| 2019-09-30 | $239.31K 10-Q · filed 2019-10-24 |
| 2019-06-30 | $278.80K 10-Q · filed 2019-07-25 |
| 2019-03-31 | $235.87K 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |